| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 108 | 1.174 | 829 | 1.810 | 2.817 | 1.260 | 952 | 0 | 117 | 0 |
| Total Income - EUR | 108 | 1.174 | 829 | 1.810 | 2.818 | 1.260 | 953 | 0 | 134 | 0 |
| Total Expenses - EUR | 501 | 1.851 | 1.217 | 2.367 | 2.597 | 1.388 | 1.408 | 755 | 762 | 622 |
| Gross Profit/Loss - EUR | -393 | -678 | -388 | -557 | 221 | -128 | -456 | -755 | -628 | -622 |
| Net Profit/Loss - EUR | -396 | -713 | -413 | -611 | 136 | -162 | -484 | -755 | -628 | -622 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biolite Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 90 | 45 | 44 | 51 | 50 | 49 | 48 | 20 | 0 | 0 |
| Current Assets | 1.798 | 1.522 | 1.373 | 1.094 | 1.826 | 1.861 | 1.624 | 1.122 | 811 | 778 |
| Inventories | 1.701 | 987 | 969 | 345 | 614 | 983 | 491 | 640 | 562 | 559 |
| Receivables | 84 | 342 | 334 | 277 | 1.043 | 694 | 662 | 312 | 193 | 192 |
| Cash | 13 | 192 | 70 | 472 | 168 | 184 | 471 | 170 | 55 | 27 |
| Shareholders Funds | -432 | -1.141 | -1.534 | -2.118 | -1.940 | -2.066 | -2.504 | -3.267 | -3.885 | -4.485 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.320 | 2.707 | 2.951 | 3.262 | 3.816 | 3.976 | 4.176 | 4.410 | 4.696 | 5.263 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Biolite Impex S.r.l.